Background The World Health Organization recommends uncomplicated P. falciparum
malaria is treated using Artemisinin‐based Combination Therapy (ACT). This review aims to …

After a longstanding global presence, malaria is now largely non-existent or suppressed in
most parts of the world. Today, cases and deaths are primarily concentrated in sub-Saharan …

Background Efficient allocation of resources to intervene against malaria requires a detailed
understanding of the contemporary spatial distribution of malaria risk. It is exactly 40 y since …

Background Information on the epidemiology of malaria is essential for designing and
interpreting results of clinical trials of drugs, vaccines and other interventions. As a …

Background Combination treatments, preferably containing an artemisinin derivative, are
recommended to improve efficacy and prevent Plasmodium falciparum drug resistance. Our …

Background Individual patient data (IPD) meta‐analysis is the gold standard. Aggregate
data (AD) and IPD can be combined using conventional pairwise meta‐analysis when IPD …

Abstract Current World Health Organization (WHO) guidelines for the treatment of
uncomplicated falciparum malaria recommend the use of artemisinin-based combination …

Objective To assess the quality of care provided by Health Surveillance Assistants (HSAs)—
a cadre of community-based health workers—as part of a national scale-up of community …

Abstract Background Artesunate-amodiaquine (AS+ AQ) and artemether-lumefantrine (AM-
L) are efficacious artemisinin combination therapy (ACT) regimens that have been widely …

Abstract Background. In 2005, Ghana adopted artemisinin-based combination therapy
(ACT) for primary treatment of falciparum malaria. A comprehensive study of the drug …